Apollon, Wyeth-Lederle Vaccines deal

Wyeth-Lederle, a unit of Wyeth-Ayerst Laboratories, acquired Apollon, a developer of DNA-based vaccine technology. Terms of the deal were undisclosed. Apollon's Genevax vaccine is in Phase II trials ...